Navigation Links
Proprietary EDM Machining Technology Boosts Speed and Accuracy for Medical Components
Date:11/17/2009

A proprietary new technology developed by Atlanta EDM & Machine Co. has successfully blended custom EDM machining and lights-out automation for greater speed and accuracy for medical industry components. Technologies that tweak the proper voltages like on and off times are critical to optimized performance.

Tucker, GA (PRWEB) November 17, 2009 -- A proprietary new technology developed by Atlanta EDM & Machine Co. has successfully blended custom EDM machining and lights-out automation for greater speed and accuracy for medical industry components. The company's technologies and extensive automation yield some of the fastest speeds in the business while still maintaining accuracies paramount to precision medical or aerospace components.

Technologies that tweak the proper voltages like on and off times are critical to optimized performance. CEO Bill McKlveen, an electrical engineer with a background in digital design and power said, “ The out of the box technologies are fine for some basic cuts, but when seconds count, being able to rely on our modifications of the spark technology allow us to maximize performance and pass along speed and ultimately savings to our customers.”

Many of the problems with production electrical discharge machining (EDM) involve bores and net geometry that need to be cut over tall blanks. Even if the resulting parts are thin, the economy of scale dictates a stacking of thin parts for cost efficiency. Many times the EDM will cut parts stacked on top of each other as high as 50 tall. Cutting 50 high at one time is efficient, but it can cause problems like tapers of holes or inaccurate profiles. Atlanta EDM’s proprietary technology has pushed the limit of the machines with break-neck speed while yielding accurate and consistent parts over a high-production volume. These thin, flat parts, which require tolerances as fine as .0002”, are routinely grouped and cut over these tall spans of material yielding accurate and cost effective parts.

Fast settings that maintain accuracy is only one of the EDM machining components used in making medical components; the other is an extensive investment in the automation tooling and management software that maximizes use of all the electrical discharge machining capital investments. As McKlveen said, “it does not make a lot of sense to put expensive equipment on the floor and not have it running every minute possible, lowering our burden rate and making our customers ultimately more competitive in the medical environment.

Consistency, accuracy and speed are the three parameters the company measures and evaluates in their ISO9001 quality program. Using the right blend of technology and automation, Atlanta EDM provides the value added EDM machining services that are required in the medical industry.

###

Read the full story at http://www.prweb.com/releases/2009/11/prweb3216824.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. RZN Nutraceuticals Receives United States Patent & Trademark Office Notice of Allowance for Proprietary HerbaZorb(TM) Absorption and Delivery System Technology Used in Popular Arthri-Zen Relief(R) and Migra-Zen Relief PLUS(R) Products
2. Research Demonstrates that HerbalSciences Proprietary Elderberry Extract Prevents in Vitro H1N1 Influenza Infection
3. Eucerin Provides BlogHer Attendees With a Glimpse Into Their Skins Future With Proprietary Time Machine Aging Simulator
4. Clinical Study Demonstrates Superior Bioavailability of Jarrow's Proprietary QH-absorb Formula
5. Prometheus Presents Proprietary Oncology Diagnostic Platform at ASCO Annual Meeting
6. ACell and Medline Announce Exclusive Marketing and Distribution Agreement for MatriStem(TM) Proprietary Bioscaffold for Wound Care
7. Home Care Delivered, Inc. Launches Proprietary Insurance Payer Management System
8. CPC Pursues Development of Proprietary Synthetic Sealants as part of MedClose(TM) Global Commercialization
9. Nostrum Pharmaceuticals Obtains Worldwide Licensing Rights From IMTECH for Clinical Development of the Small Molecule Caerulomycin and Its Proprietary Derivatives for Their Novel Indication of Immunosuppression
10. Frost & Sullivan Awards SourceOne Global Partners for Proprietary Heart Health Formulas
11. Aduromed Files Patent Application to Cover Proprietary New Standard for Containerized, Turnkey Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... 06, 2016 , ... Experimentation involving human stem cells (HSCs) ... to its potential for revolutionizing human disease treatment. There are multiple HSC platforms ... cells (hiPSCs). , Both platforms have distinct advantages and disadvantages, but what ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a ... world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... TopConsumerReviews.com recently ... Mobility Scooters . , Mobility Scooters give freedom to people who need help ... Still others may be facing a long period of rehabilitation after an illness or ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is ... natural lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO ... to create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... CRANBURY, N.J. , Dec. 5, 2016 /PRNewswire/ ... pharmaceutical company, today presented data from two Phase ... poster sessions at the 58th annual meeting of ... San Diego, California . The two ... patients with acute myeloid leukemia (AML) and T-cell ...
(Date:12/5/2016)... Dec. 5, 2016   Lexicon Pharmaceuticals, Inc. ... from a Phase 2 clinical study of sotagliflozin, a ... collaboration with JDRF, the leading global organization funding type ... Phase 2 clinical trial, which randomized a total of ... once-daily 400 mg dose of sotagliflozin compared to a ...
(Date:12/5/2016)... 5, 2016  Sharn Anesthesia Inc. announced today that ... distribution partner for Salter Labs.  The company also received ... recognition of outstanding sales performance. Salter Labs ... anesthesia care, including the market gold standard ECO 2 ... distributor of the Parker Flex-Tip® Endotracheal Tube, which is ...
Breaking Medicine Technology: